Quality of life (Qol) with capecitabine in patients with metastatic colorectal cancer (MCRC) (2005)
Nome do evento: ECCO 13: The European Cancer Conference. Unidade: FMAssuntos: NEOPLASIAS MAMÁRIAS, FÁRMACOS, NEOPLASIAS COLORRETAIS, QUALIDADE DE VIDA
ABNT
BEATO, C. A. M et al. Quality of life (Qol) with capecitabine in patients with metastatic colorectal cancer (MCRC). . Paris: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 jul. 2024. , 2005APA
Beato, C. A. M., Van Eyll, B., Federico, M. H., Perdicaris, M. R., Skare, N., Cabral, S., et al. (2005). Quality of life (Qol) with capecitabine in patients with metastatic colorectal cancer (MCRC). Paris: Faculdade de Medicina, Universidade de São Paulo.NLM
Beato CAM, Van Eyll B, Federico MH, Perdicaris MR, Skare N, Cabral S, Saltz E, Franke F, Moura GL, Paula FU. Quality of life (Qol) with capecitabine in patients with metastatic colorectal cancer (MCRC). 2005 ; 3( 2): 365.[citado 2024 jul. 02 ]Vancouver
Beato CAM, Van Eyll B, Federico MH, Perdicaris MR, Skare N, Cabral S, Saltz E, Franke F, Moura GL, Paula FU. Quality of life (Qol) with capecitabine in patients with metastatic colorectal cancer (MCRC). 2005 ; 3( 2): 365.[citado 2024 jul. 02 ]